TriSalus Life Sciences Files 8-K

Ticker: TLSIW · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1826667

Trisalus Life Sciences, Inc. 8-K Filing Summary
FieldDetail
CompanyTrisalus Life Sciences, Inc. (TLSIW)
Form Type8-K
Filed DateJun 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-reporting

TL;DR

TriSalus Life Sciences filed an 8-K on 6/23/25, mostly financial docs. Nothing major announced.

AI Summary

On June 23, 2025, TriSalus Life Sciences, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure related to the company's financial status. No specific material events or transactions were detailed in the provided excerpt.

Why It Matters

This 8-K filing serves as a public record of TriSalus Life Sciences, Inc.'s financial disclosures, providing transparency to investors and stakeholders.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, with no indication of significant new risks or events.

Key Players & Entities

  • TriSalus Life Sciences, Inc. (company) — Registrant
  • MedTech Acquisition Corp (company) — Former company name
  • June 23, 2025 (date) — Date of report

FAQ

What is the primary purpose of this 8-K filing for TriSalus Life Sciences, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 23, 2025.

When was the report filed?

The report was filed on June 23, 2025.

What was TriSalus Life Sciences, Inc.'s former company name?

TriSalus Life Sciences, Inc.'s former company name was MedTech Acquisition Corp.

In which state was TriSalus Life Sciences, Inc. incorporated?

TriSalus Life Sciences, Inc. was incorporated in Delaware.

What is the principal executive office address for TriSalus Life Sciences, Inc.?

The principal executive office address is 6272 W 91st Ave, Westminster, Colorado 80031.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding TriSalus Life Sciences, Inc. (TLSIW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.